Related Experiment Video
Updated: Oct 22, 2025
06:14
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
6.9K
Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses
Brent A Stanfield1, Konstantin G Kousoulas2,3, Agustin Fernandez3
1Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Viruses
|August 28, 2021
Summary
Developing novel live-attenuated vaccines offers hope for preventing and treating human herpes simplex virus (HSV) infections. These next-generation vaccines aim to provide long-lasting immunity against HSV-1 and HSV-2, addressing a significant unmet medical need.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Human herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) cause widespread diseases, including encephalitis, keratitis, and orofacial/genital herpes.
- HSV establishes lifelong latency in neurons, with periodic reactivation causing painful lesions and significant economic burden.
- Current treatment options are limited, and no FDA-approved vaccines exist for HSV infections, despite numerous failed clinical trials.
Purpose of the Study:
- To review recent advancements in the development of herpes simplex virus vaccines.
- To discuss the current status of clinical trials for HSV vaccines.
- To highlight the potential of live-attenuated vaccines for prophylactic and therapeutic applications against HSV.
Main Methods:
- Review of scientific literature on HSV pathogenesis and vaccine development.
- Analysis of recent preclinical and clinical trial data for novel HSV vaccine candidates.
- Discussion of vaccine design strategies based on immunopathogenesis.
Main Results:
- Novel live-attenuated vaccine approaches show high efficacy in preclinical models.
- Next-generation vaccines are designed for safety, reduced side effects, and robust immune responses.
- Ongoing clinical trials are evaluating these advanced vaccine candidates.
Conclusions:
- Live-attenuated vaccines represent a promising strategy for combating HSV infections.
- Effective prophylactic and therapeutic vaccines are crucial for reducing the global burden of HSV diseases.
- Continued research and clinical evaluation are essential to achieve an effective HSV vaccine.
